Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × Terminated × Has announcements × Clear all

Phase

Phase 2 5 Phase 3 2 Phase 1 2 Phase 2/3 1

Status

Completed 11 Active not recruiting 3 Terminated 2 Recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2 Lymphoid 1

Conditions

Neuroblastoma 1 Neoplasms 1 Lymphoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

TIC10 compound 1 Crizotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03416530 2025-02-14

ONC201 in Pediatric H3 K27M Gliomas

Jazz Pharmaceuticals

Phase 1 Terminated

134 enrolled 1 FDA

Diffuse Intrinsic Pontine Glioma, Glioma

NCT01121588 2025-01-23

Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Pfizer

Phase 1 Terminated

44 enrolled 22 charts 1 FDA

Lymphoma, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡